A Jacobs

534 total citations
12 papers, 421 citations indexed

About

A Jacobs is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, A Jacobs has authored 12 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in A Jacobs's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). A Jacobs is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). A Jacobs collaborates with scholars based in United Kingdom, Germany and United States. A Jacobs's co-authors include Rose Ann Padua, Mark Worwood, David Oscier, S. Ridge, Anna Janowska‐Wieczorek, E. Richard Stanley, David Bowen, Elisabeth Paietta, AR Belch and R Bailey-Wood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and American Journal of Obstetrics and Gynecology.

In The Last Decade

A Jacobs

12 papers receiving 410 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A Jacobs 240 158 120 97 92 12 421
A Severino 297 1.2× 117 0.7× 98 0.8× 131 1.4× 104 1.1× 16 429
JM Hernández 346 1.4× 187 1.2× 115 1.0× 100 1.0× 51 0.6× 12 426
S Furusawa 226 0.9× 129 0.8× 57 0.5× 90 0.9× 72 0.8× 35 396
J H Ohyashiki 205 0.9× 199 1.3× 54 0.5× 98 1.0× 60 0.7× 24 457
M V Joyner 297 1.2× 131 0.8× 145 1.2× 161 1.7× 96 1.0× 24 444
Emma L. Clarke 318 1.3× 57 0.4× 177 1.5× 85 0.9× 107 1.2× 12 435
Eileen C. Hannon 358 1.5× 145 0.9× 174 1.4× 197 2.0× 129 1.4× 9 578
Curtis Je 220 0.9× 167 1.1× 88 0.7× 56 0.6× 78 0.8× 12 388
RP Castleberry 235 1.0× 195 1.2× 62 0.5× 143 1.5× 67 0.7× 9 469
D. C. van der Plas 344 1.4× 192 1.2× 78 0.7× 147 1.5× 75 0.8× 11 498

Countries citing papers authored by A Jacobs

Since Specialization
Citations

This map shows the geographic impact of A Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Jacobs more than expected).

Fields of papers citing papers by A Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Jacobs. The network helps show where A Jacobs may publish in the future.

Co-authorship network of co-authors of A Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of A Jacobs. A scholar is included among the top collaborators of A Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Jacobs. A Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Marcus, R. E., Alain Delmer, H. Zwierzina, et al.. (1994). A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.. PubMed. 8(1). 16–23. 40 indexed citations
3.
Jacobs, A, et al.. (1991). Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein.. PubMed. 5(12). 1050–3. 17 indexed citations
4.
Janowska‐Wieczorek, Anna, AR Belch, A Jacobs, et al.. (1991). Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood. 77(8). 1796–1803. 81 indexed citations
5.
Holmes, J. A., et al.. (1990). Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data. British Journal of Cancer. 62(2). 209–212. 37 indexed citations
6.
Ridge, S., Mark Worwood, David Oscier, A Jacobs, & Rose Ann Padua. (1990). FMS mutations in myelodysplastic, leukemic, and normal subjects.. Proceedings of the National Academy of Sciences. 87(4). 1377–1380. 167 indexed citations
7.
Visani, Giuseppe, Alain Delmer, H. Zwierzina, et al.. (1989). Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.. PubMed. 4 Suppl 3. 36–7. 5 indexed citations
8.
Baines, Paul, et al.. (1987). Enrichment of progenitor cells from human marrow.. PubMed. 15(7). 809–13. 5 indexed citations
9.
Jacobs, A. (1986). Myelofibrosis: Pathophysiology and Clinical Management. Journal of Clinical Pathology. 39(3). 347–347. 42 indexed citations
10.
Tennant, G. B., A Jacobs, & R Bailey-Wood. (1986). Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.. PubMed. 14(11). 1063–8. 18 indexed citations
11.
Jacobs, A. (1979). Advances in red cell anomalies.. PubMed. 21(1). 67–74. 1 indexed citations
12.
Jacobs, A. (1972). Blood Disorders in the Elderly. Journal of Clinical Pathology. 25(2). 183.3–184. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026